Flexion Therapeutics to Report First-Quarter 2019 Financial Results on May 8, 2019
May 01 2019 - 4:30PM
Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it
will report its first-quarter 2019 financial results after the
close of the U.S. financial markets on Wednesday, May 8, 2019.
Flexion’s management will host a conference call at 4:30 p.m. ET to
discuss the results and provide an update on business
operations.
The dial-in number for the conference call is 855-770-0022 for
domestic participants and 908-982-4677 for international
participants, with Conference ID #1529779. A live webcast of
the conference call can also be accessed through the “Investors”
tab on the Flexion Therapeutics website, and a replay will be
available online after the call.
About Flexion Therapeutics Flexion
Therapeutics (Nasdaq:FLXN) is a biopharmaceutical company
focused on the development and commercialization of novel, local
therapies for the treatment of patients with musculoskeletal
conditions, beginning with osteoarthritis, a type of degenerative
arthritis. The Company's core values are focus, ingenuity,
tenacity, transparency and fun. For the past two years, Flexion has
been named one of the Best Places to Work by the Boston
Business Journal, and a Top Place to Work
in Massachusetts by The Boston
Globe.
Contact:
Scott YoungVice President, Corporate Communications &
Investor RelationsT:
781-305-7194syoung@flexiontherapeutics.com
Flexion Therapeutics (NASDAQ:FLXN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Flexion Therapeutics (NASDAQ:FLXN)
Historical Stock Chart
From Apr 2023 to Apr 2024